Keywords: Retinal theraapeutics, USA, Market forecasts, Frost & Sullivan, Avastin, Lucentis, Roche, Genentech

US retinal therapeutics market buoyant, says F&S

Article | 07 May 2012

Print This

Alarm bells are ringing loud and clear as diabetes has grown to epidemic proportions worldwide, triggering intensive ophthalmic research into ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in